Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Genetic Analysis of UK Biobank Participants

Published: Friday, March 22, 2013
Last Updated: Friday, March 22, 2013
Bookmark and Share
UK Biobank announces plans to undertake detailed DNA analysis of its 500,000 participants to better understand the complex interaction of lifestyle and genes in causing life-threatening and disabling disorders.

This genotyping project which will cost over £20 million will examine hundreds and thousands of genetic ‘markers’ on each UK Biobank participant.  The genotyping will be undertaken by Affymetrix UK Ltd and AffymetrixInc, following an agreement signed with UK Biobank earlier today. The work will create hundreds of billions of packets of new data that will help scientists tackle disease. Data will become available over the course of the next two years.
The Medical Research Council and the Department of Health have each contributed £10m towards the project, with the British Heart Foundation (BHF) providing a further £1m.
Minister for Universities and Science David Willetts said:
“UK Biobank is a unique resource to researchers in the UK and throughout the world because it is studying such a large number of people over such a long period of time. This new investment will allow the study to truly reach its potential and maximise the value of its data. Using the most advanced analysis techniques will bring about a totally new era in our understanding of how genetics and the environment can interact to cause diseases such as dementia, perhaps years in advance of symptoms.”
Health Minister Lord Howesaid:
“Thanks to the half a million volunteers who donated their DNA, researchers will have access to a unique resource in UK Biobank.
“The significance of this new scientific work should not be under-estimated. The genetic information generated will improve our understanding of hundreds of conditions and support health and life sciences industry researchers to develop improved diagnosis and treatments.
“It shows once again how Government funding is putting the UK at the forefront of world-leading health research.”
BHF Professor Rory Collins, UK Biobank CEO and Principal Investigator, said:
“UK Biobank is pleased to join forces with Affymetrix for this next phase of the UK Biobank project. The two organizations will work closely together to ensure that world class data are provided quickly and securely to help scientists working on the causes of a wide range of life-threatening and disabling diseases.
“I urge health scientists everywhere to think carefully about how this resource could be used to help their research, and to register with UK Biobank. I am also very grateful to the half a million participants whose generosity and vision for the future has allowed this resource to grow.”
Professor Peter Donnelly, Director of the Wellcome Trust Centre for Human Genetics, at the University of Oxford, said UK Biobank’s power is in its size and the richness of information already collected on participants, coupled with this additional data from genotyping. The work will provide information on genes, but also on the DNA between them, thought to play an important role in switching them on and off.
“This research is going to provide completely new clues to the biological processes that lead to diseases, and new ideas for successful intervention and treatment.”

The work will also help to explain why some people respond better to treatments, or have worse side effects. “This is about homing in on biological mechanisms underlying disease that we’re as yet unaware of, and to disentangle those processes to tackle a wide range of common illnesses,” he said.
DNA will be extracted from blood stored by UK Biobank. Affymetrix will use the latest technologies to measure genetic variations of the 500,000 participants. The work will be done safely and securely in the US and in such a way that participant anonymity is maintained.
The genetic data will be returned to UK Biobank which will enable approved researchers registered with UK Biobank (conducting bona fide health related research in the public interest) to correlate genetic differences together with other health and lifestyle factors such as diet and activity levels to the incidence of disease.
UK Biobank recruited 500,000 participants between 2006 and 2010 from 22 assessment centres in England, Scotland and Wales. UK Biobankis a charity,funded primarily by the MRC, Department of Health, Wellcome Trust, Scottish Government, Welsh Assembly Government and the BHF.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Novel Proteins Linked to Huntington's Disease
University of Florida Health researchers have made a new discovery about Huntington's disease, showing that the gene that causes the fatal disorder makes an unexpected "cocktail" of mutant proteins that accumulate in the brain.
Enzyme Critical to Maintaining Telomere Length Discovered
New method expected to speed understanding of short telomere diseases and cancer.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos